Obesity
| Interventional and Clinical Studies
Obesity
Interventional and Clinical Studies
Tolerability and Weight Reduction of Tirzepatide in Adults with Obesity or Overweight in SURMOUNT-1 trial
book_2
Source:
ObesityWeek 2023 - Oral presentation
calendar_today
Published on Medfyle:
November 2023
import_contacts
3
min
In this medfyle
In SURMOUNT-1 trial, tirzepatide-induced weight reduction seems unrelated to gastrointestinal adverse events
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of a presentation given at the ObesityWeek®️ 2023.
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content.
©️2023 Infomedica-Medfyle. All rights reserved.
